Colombo Charles G MD is categorized under Ophthalmologists in Rochester, MI and active since 1971.
Colombo Charles G MD was established in 1971, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Ophthalmologists business, which does work in the B2C market, and is classified as a Ophthalmologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Charles Colombo at the company’s single location by writing to 1701 South Boulevard East # 180, Rochester, Michigan MI 48307 or by phoning (248) 293-1000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Colombo Charles G MD |
| Contact Person: | Charles Colombo |
| Address: | 1701 South Boulevard East # 180, Rochester, Michigan 48307 |
| Phone Number: | (248) 293-1000 |
| Website Address: | troyeyecare.net |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1971 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Ophthalmologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Colombo Charles G MD was started in 1971 to provide professional Ophthalmologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Charles Colombo for inquiries that concern Colombo Charles G MD by calling the company number (248) 293-1000, as your correspondence is most welcome. Additionally, the physical location of the single location of Colombo Charles G MD can be found at the coordinates 42.62407,-83.09621 as well as the street address 1701 South Boulevard East # 180 in Rochester, Michigan 48307.
For its online presence, you may visit Colombo Charles G MD’s website at troyeyecare.net and engage with its social media outlets through on Twitter and on Facebook.